Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis.
El Kassas M, Abdeen N, Omran D, Alboraie M, Salaheldin M, Eltabbakh M, Farghaly R, Emadeldeen M, Afify S, Sweedy A, Ghalwash A, Abbass A, Ezzat S, Tahoon M, ELshazly HM, Hamdy H, Omar H.
El Kassas M, et al. Among authors: ghalwash a.
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e877-e882. doi: 10.1097/MEG.0000000000002287.
Eur J Gastroenterol Hepatol. 2021.
PMID: 34560693